Isomyosamine

N/A

Report date: 2025/05/20 15:34:40
NME

Base Information

Drug NameIsomyosamine
Drug Alias NameIsomiosamineIsomyosmineMYMD-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 17A modulatorsInterleukin-6 modulatorsTumor necrosis factor α modulators
TargetsTumor necrosis factor αInterleukin 17AInterleukin-6
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Healthy AgingAnxiety +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMymd Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMymd Pharmaceuticals IncTNF Pharmaceuticals IncJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Healthy AgingAnxiety +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A